Clinical Trials Logo

Post-Concussion Symptoms clinical trials

View clinical trials related to Post-Concussion Symptoms.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03400813 Completed - Clinical trials for Post-Traumatic Stress Disorder

Eye-Movement Desensitization and Post-Traumatic Syndroms

SOFTER3
Start date: January 15, 2018
Phase: N/A
Study type: Interventional

Millions people, all over the world, are admitted in the Emergency Department after a trauma or simply to receive medical cares. In France, it represents 10 million patients. Probably because of stress associated with the event, 20% will suffer a combination of non-specifics symptoms which persist for many months and with daily life quality impairment. The investigators hypothesize that an early intervention, such as Eye-Movement, Desensitization and Reprocessing (EMDR) could be performed in the ED and could prevent the occurrence of these symptoms.

NCT ID: NCT03213730 Completed - Brain Concussion Clinical Trials

Perceptual-Cognitive Training After a Mild Traumatic Brain Injury: Towards a Sensitive Marker for Recovery

Start date: January 10, 2017
Phase: N/A
Study type: Interventional

This study is part of a larger, multi-centered project done with the collaboration of University Of Victoria. This study holds three separate studies on the mild traumatic brain injured population and the use of perceptual-cognitive training (3D-MOT).

NCT ID: NCT02709369 Completed - Anxiety Clinical Trials

HIRREM Developmental Study

Start date: August 23, 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to explore the functional and physiological effects associated with the use of High-resolution, relational, resonance-based, electroencephalic mirroring (HIRREM), as supplemental care, for symptoms of neurological, cardiovascular, and neuropsychological disorders. This is a non-randomized, open label, and unblinded before-and-after trial, evaluating the effect of HIRREM on an objective, physiological common denominator (heart rate variability, HRV), across a variety of relevant conditions, as well as changes in clinical symptoms inventories, to generate hypotheses and pilot data for investigation in future proposals.

NCT ID: NCT02374918 Completed - Concussion, Mild Clinical Trials

Bright Light Therapy for Treatment of Sleep Problems Following Mild Traumatic Brain Injury

Start date: December 2014
Phase: N/A
Study type: Interventional

The purpose of the research study is to understand the effectiveness of a six-week course of light exposure on cognitive functioning, mood, activity, and sleep in people that have suffered a head injury leading to a concussion.

NCT ID: NCT02118220 Completed - Clinical trials for Post Concussion Symptoms

Effects of Anesthesia on Pediatric Surgical Patients With a History of Concussion - Phase I

Start date: May 2014
Phase: Phase 1
Study type: Interventional

The purpose of this research study is to determine the number of children who have symptoms of a concussion at the time they are scheduled for orthopedic surgery at Boston Children's Hospital. It is currently unknown if anesthesia affects a child with a previously diagnosed concussion. This study is the first phase of a two-part study looking at the effects of anesthesia in children undergoing orthopedic surgery with a previous concussion. Currently, the decision to continue with surgery in patients with a diagnosed concussion is based on clinical judgment by the patients.

NCT ID: NCT01747811 Completed - Concussion, Mild Clinical Trials

Effects of Bright Light Therapy in Mild Traumatic Brain Injury

Start date: December 2010
Phase: N/A
Study type: Interventional

Mild traumatic brain injuries (mTBI) or "concussions" are an increasingly prevalent injury in our society. Patients with post-concussion syndrome have been shown to have deficits on tests of short term memory, divided attention, multi-tasking, information processing speed, and reaction time, as well as alteration in mood and emotional functioning. Many patients have other vague complaints including fatigue, dizziness, irritability, sleep disturbances, and chronic headaches. Furthermore, sleep disruption of one of the most common complaints in patients suffering from traumatic brain injuries, with as many as 40 to 65% of patients with mTBI complaining of insomnia. Sleep problems in these patients are associated with poorer outcome, while resolution of the sleep disturbance is associated with improvement in cognitive functioning. Despite recent evidence of the correlation between sleep quality and recovery from traumatic brain injury, and the well-established role of sleep in neural plasticity and neurogenesis, there have been virtually no direct studies of the causal effects of sleep on recovery following mTBI. However, it is quite likely that sleep plays a critical role in recovery following brain injury. A particularly promising non-pharmacologic approach that shows potential in improving/modifying abnormalities of the circadian rhythm and sleep-wake schedule is bright light therapy. For the proposed investigation, we hypothesize that bright light therapy may be helpful in improving the sleep of patients with a recent history of mTBI and may also have other mood elevating effects, both of which should promote positive treatment outcome in these individuals. Bright light therapy may increase the likelihood that they will recover more quickly, benefit more extensively from other forms of therapy, and build emotional and cognitive resilience.

NCT ID: NCT00142090 Completed - Brain Concussion Clinical Trials

Use of Salt-Water Solution to Improve Symptoms in Concussion

Start date: November 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to find out if 3% hypertonic saline (salt-water solution) given in a vein improves the headache that may be caused by a concussion. 3% hypertonic saline may also improve some of the other symptoms that may be caused by concussion (for example: confusion, nausea, vomiting). This research is being done because there have been previous experience which suggests that 3% hypertonic saline has been beneficial in the treatment of children with more severe brain injury.